2026-10-15 - LD Paris - Merz v. Viatris Sant - UPC-CFI-0001901/2026

Aktenzeichen:
UPC-CFI-0001901/2026
Datum:
Spruchkörper:
Court of First Instance - Paris (FR) Local Division
Art:
Order
Parteien:
Merz Pharma France, Merz Therapeutics GmbH, Merz Pharmaceuticals LLC v. Viatris Santé

Kernaussage: The full panel of the Paris Local Division decided a defendant's procedural application to bifurcate its counterclaim for revocation of an SPC and to stay that counterclaim in view of an earlier stand-alone revocation action before the Paris Tribunal judiciaire.

2026-10-15 - LD Paris - Merz v. Viatris Sant - UPC-CFI-0001901/2026
🏛️Court of First Instance - Paris (FR) Local Division• Order
📅2026-10-15
🔢UPC-CFI-0001901/2026
Parteien & Vertreter
Kläger / Berufungsführer
Merz Pharma France
Merz Therapeutics GmbH
Merz Pharmaceuticals LLC
Laëtitia BÉNARD
Beklagter / Berufungsbeklagter
Viatris Santé
Marc LAUZERAL
⚖️Infringement Action
🌐English

routine
The full panel of the Paris Local Division decided a defendant's procedural application to bifurcate its counterclaim for revocation of an SPC and to stay that counterclaim in view of an earlier stand-alone revocation action before the Paris Tribunal judiciaire. Because the application concerned bifurcation under Art. 33(3) UPCA and R. 37.2 RoP, the panel, not the judge-rapporteur, decided it. With both parties in agreement, the panel referred the counterclaim to the Paris Central Division, which holds competence for the validity of the SPC under Annex II, and left the lis pendens stay question under Art. 31 UPCA and Arts. 29-30 Brussels I recast to that division. The infringement action continues before the Paris LD for reasons of procedural efficiency.
Stichwörter
Bifurcation - Stay - Parallel proceedings - Article 33.3 (b) UPCA - Rule 37.2 RoP

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren